Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists.
de Heide J, van der Graaf M, Holl MJ, Bhagwandien RE, Theuns DAMJ, de Wit A, Zijlstra F, Szili-Torok T, Lenzen MJ, Yap SC.
Int J Cardiol Heart Vasc. 2022 Mar 16;39:101005. doi: 10.1016/j.ijcha.2022.101005. eCollection 2022 Apr.
An atypical pacemaker pocket hematoma containing chyliform fluid.
Maffè S, Paffoni P, Bergamasco L, Arrondini M, Dellavesa P.
Indian Pacing Electrophysiol J. 2022 May-Jun;22(3):161-164. doi: 10.1016/j.ipej.2022.03.002. Epub 2022 Apr 1.
Pocket Hematoma: A Call for Definition.
DE Sensi F, Miracapillo G, Cresti A, Severi S, Airaksinen KE.
Pacing Clin Electrophysiol. 2015 Aug;38(8):909-13. doi: 10.1111/pace.12665. Epub 2015 Jun 11.
Sub-pocket small-hole drainage for pocket hematoma after cardiac device implantation.
Wei Y, Cai L, Wu X, Zhou G, Lu X, Peng S, Ding Y, Xu J, Chen S, Ouyang P, Liu S.
Herz. 2022 Feb;47(1):63-66. doi: 10.1007/s00059-021-05037-y. Epub 2021 Apr 22.
Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.
Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F.
Chest. 2004 Oct;126(4):1177-86. doi: 10.1378/chest.126.4.1177.
Pacemaker pocket infection rate and suture technique.
Datta G.
Turk Kardiyol Dern Ars. 2020 Jan;48(1):44-48. doi: 10.5543/tkda.2019.82598.
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).
Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.
Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.
Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study).
Malagù M, Trevisan F, Scalone A, Marcantoni L, Sammarco G, Bertini M.
Am J Cardiol. 2017 Apr 1;119(7):1036-1040. doi: 10.1016/j.amjcard.2016.12.012. Epub 2017 Jan 6.
Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).
Turagam MK, Nagarajan DV, Bartus K, Makkar A, Swarup V.
J Interv Card Electrophysiol. 2017 Aug;49(2):197-204. doi: 10.1007/s10840-017-0235-9. Epub 2017 Apr 17.
The relationship between pocket hematoma and risk of wound infection among patients with a cardiovascular implantable electronic device: An integrative review.
Song J, Tark A, Larson EL.
Heart Lung. 2020 Jan-Feb;49(1):92-98. doi: 10.1016/j.hrtlng.2019.09.009. Epub 2019 Oct 10.
